vs
Side-by-side financial comparison of BALCHEM CORP (BCPC) and Duolingo, Inc. (DUOL). Click either name above to swap in a different company.
Duolingo, Inc. is the larger business by last-quarter revenue ($282.9M vs $263.6M, roughly 1.1× BALCHEM CORP). BALCHEM CORP runs the higher net margin — 14.9% vs 14.8%, a 0.0% gap on every dollar of revenue. On growth, Duolingo, Inc. posted the faster year-over-year revenue change (35.0% vs 9.8%). Over the past eight quarters, Duolingo, Inc.'s revenue compounded faster (29.9% CAGR vs 4.9%).
Balchem Corp is a global specialty chemicals and nutritional ingredients provider that develops, manufactures and distributes application-specific products for human nutrition, animal health, pharmaceutical and industrial end markets, serving customers across North America, Europe and Asia Pacific.
Duolingo, Inc. is a leading global edtech firm operating a gamified language learning platform. It offers free and premium self-paced courses for over 40 languages, plus language certification, math learning tools, and literacy programs, serving individual learners, schools and corporate clients worldwide.
BCPC vs DUOL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $263.6M | $282.9M |
| Net Profit | $39.2M | $42.0M |
| Gross Margin | 35.6% | 72.8% |
| Operating Margin | 19.8% | 15.4% |
| Net Margin | 14.9% | 14.8% |
| Revenue YoY | 9.8% | 35.0% |
| Net Profit YoY | 16.8% | 201.7% |
| EPS (diluted) | $1.21 | $0.99 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $263.6M | $282.9M | ||
| Q3 25 | $267.6M | $271.7M | ||
| Q2 25 | $255.5M | $252.3M | ||
| Q1 25 | $250.5M | $230.7M | ||
| Q4 24 | $240.0M | $209.6M | ||
| Q3 24 | $239.9M | $192.6M | ||
| Q2 24 | $234.1M | $178.3M | ||
| Q1 24 | $239.7M | $167.6M |
| Q4 25 | $39.2M | $42.0M | ||
| Q3 25 | $40.3M | $292.2M | ||
| Q2 25 | $38.3M | $44.8M | ||
| Q1 25 | $37.1M | $35.1M | ||
| Q4 24 | $33.6M | $13.9M | ||
| Q3 24 | $33.8M | $23.4M | ||
| Q2 24 | $32.1M | $24.4M | ||
| Q1 24 | $29.0M | $27.0M |
| Q4 25 | 35.6% | 72.8% | ||
| Q3 25 | 35.7% | 72.5% | ||
| Q2 25 | 36.4% | 72.4% | ||
| Q1 25 | 35.2% | 71.1% | ||
| Q4 24 | 36.0% | 71.9% | ||
| Q3 24 | 35.6% | 72.9% | ||
| Q2 24 | 35.5% | 73.4% | ||
| Q1 24 | 34.0% | 73.0% |
| Q4 25 | 19.8% | 15.4% | ||
| Q3 25 | 20.4% | 12.9% | ||
| Q2 25 | 20.1% | 13.2% | ||
| Q1 25 | 20.4% | 10.2% | ||
| Q4 24 | 19.8% | 6.6% | ||
| Q3 24 | 20.0% | 7.0% | ||
| Q2 24 | 19.6% | 10.5% | ||
| Q1 24 | 17.4% | 9.8% |
| Q4 25 | 14.9% | 14.8% | ||
| Q3 25 | 15.1% | 107.5% | ||
| Q2 25 | 15.0% | 17.8% | ||
| Q1 25 | 14.8% | 15.2% | ||
| Q4 24 | 14.0% | 6.6% | ||
| Q3 24 | 14.1% | 12.1% | ||
| Q2 24 | 13.7% | 13.7% | ||
| Q1 24 | 12.1% | 16.1% |
| Q4 25 | $1.21 | $0.99 | ||
| Q3 25 | $1.24 | $5.95 | ||
| Q2 25 | $1.17 | $0.91 | ||
| Q1 25 | $1.13 | $0.72 | ||
| Q4 24 | $1.03 | $0.31 | ||
| Q3 24 | $1.03 | $0.49 | ||
| Q2 24 | $0.98 | $0.51 | ||
| Q1 24 | $0.89 | $0.57 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $74.6M | $1.0B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.3B | $1.3B |
| Total Assets | $1.7B | $2.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $74.6M | $1.0B | ||
| Q3 25 | $65.1M | $1.0B | ||
| Q2 25 | $65.4M | $976.2M | ||
| Q1 25 | $49.9M | $884.0M | ||
| Q4 24 | $49.5M | $785.8M | ||
| Q3 24 | $73.7M | $854.4M | ||
| Q2 24 | $63.7M | $888.2M | ||
| Q1 24 | $60.3M | $829.7M |
| Q4 25 | $1.3B | $1.3B | ||
| Q3 25 | $1.3B | $1.3B | ||
| Q2 25 | $1.3B | $977.0M | ||
| Q1 25 | $1.2B | $893.8M | ||
| Q4 24 | $1.1B | $824.5M | ||
| Q3 24 | $1.2B | $822.5M | ||
| Q2 24 | $1.1B | $766.9M | ||
| Q1 24 | $1.1B | $711.1M |
| Q4 25 | $1.7B | $2.0B | ||
| Q3 25 | $1.7B | $1.9B | ||
| Q2 25 | $1.7B | $1.5B | ||
| Q1 25 | $1.6B | $1.4B | ||
| Q4 24 | $1.6B | $1.3B | ||
| Q3 24 | $1.6B | $1.2B | ||
| Q2 24 | $1.6B | $1.1B | ||
| Q1 24 | $1.6B | $1.1B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $67.3M | $107.3M |
| Free Cash FlowOCF − Capex | — | $96.6M |
| FCF MarginFCF / Revenue | — | 34.1% |
| Capex IntensityCapex / Revenue | — | 3.8% |
| Cash ConversionOCF / Net Profit | 1.72× | 2.56× |
| TTM Free Cash FlowTrailing 4 quarters | — | $369.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $67.3M | $107.3M | ||
| Q3 25 | $65.6M | $84.2M | ||
| Q2 25 | $47.3M | $90.7M | ||
| Q1 25 | $36.5M | $105.6M | ||
| Q4 24 | $52.3M | $83.3M | ||
| Q3 24 | $51.3M | $56.3M | ||
| Q2 24 | $45.0M | $62.4M | ||
| Q1 24 | $33.4M | $83.5M |
| Q4 25 | — | $96.6M | ||
| Q3 25 | — | $79.4M | ||
| Q2 25 | — | $89.5M | ||
| Q1 25 | — | $104.3M | ||
| Q4 24 | — | $81.4M | ||
| Q3 24 | — | $53.1M | ||
| Q2 24 | — | $56.8M | ||
| Q1 24 | — | $82.1M |
| Q4 25 | — | 34.1% | ||
| Q3 25 | — | 29.2% | ||
| Q2 25 | — | 35.5% | ||
| Q1 25 | — | 45.2% | ||
| Q4 24 | — | 38.8% | ||
| Q3 24 | — | 27.6% | ||
| Q2 24 | — | 31.9% | ||
| Q1 24 | — | 49.0% |
| Q4 25 | — | 3.8% | ||
| Q3 25 | — | 1.8% | ||
| Q2 25 | — | 0.5% | ||
| Q1 25 | — | 0.6% | ||
| Q4 24 | — | 0.9% | ||
| Q3 24 | — | 1.7% | ||
| Q2 24 | — | 3.1% | ||
| Q1 24 | — | 0.8% |
| Q4 25 | 1.72× | 2.56× | ||
| Q3 25 | 1.63× | 0.29× | ||
| Q2 25 | 1.23× | 2.02× | ||
| Q1 25 | 0.98× | 3.01× | ||
| Q4 24 | 1.56× | 5.99× | ||
| Q3 24 | 1.52× | 2.41× | ||
| Q2 24 | 1.40× | 2.56× | ||
| Q1 24 | 1.15× | 3.10× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BCPC
| Human Nutrition And Health | $166.1M | 63% |
| Animal Nutrition And Health | $61.2M | 23% |
| Specialty Products | $34.8M | 13% |
DUOL
| License And Service | $242.3M | 86% |
| Advertising | $20.2M | 7% |
| English Test | $10.3M | 4% |
| Other | $10.1M | 4% |
